Compare Suncare Traders with Similar Stocks
Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -7.25% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -1.14
Negative results in Mar 26
Risky - Negative EBITDA
Stock DNA
Trading & Distributors
INR 13 Cr (Micro Cap)
19.00
18
0.00%
0.14
1.61%
0.31
Total Returns (Price + Dividend) 
Suncare Traders for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Suncare Traders Ltd Falls to 52-Week Low of Rs 0.43 as Sell-Off Deepens
For the second consecutive session, Suncare Traders Ltd has succumbed to selling pressure, hitting a fresh 52-week low of Rs 0.43 on 18 May 2026. This decline comes amid a broader market downturn, but the stock’s underperformance is notably sharper than its sector peers.
Read full news articleAre Suncare Traders Ltd latest results good or bad?
Suncare Traders Ltd's latest financial results reflect a challenging operational environment characterized by significant volatility and fundamental weaknesses. In the most recent quarter ending December 2025, the company reported net sales of ₹0.00 crores, indicating no year-over-year growth compared to the previous year, which also faced a drastic decline. This stagnation in revenue highlights the company's struggle to establish a consistent operational momentum. The standalone net profit for the same period was ₹0.28 crores, which represents a decline of 63.16% year-over-year. This sharp decrease in profitability raises concerns about the sustainability of the company's earnings, especially as the operating profit margin excluding other income remained at 0.00%, suggesting that core business operations are not generating positive cash flows. Overall, Suncare Traders Ltd's financial trajectory continues...
Read full news article Announcements 
Compliances-Reg.24(A)-Annual Secretarial Compliance
21-May-2026 | Source : BSEPFA
Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)
07-May-2026 | Source : BSEPFA
Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015
07-May-2026 | Source : BSEPFA
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
Suncare Traders Ltd has announced 2:10 stock split, ex-date: 06 Mar 20
Suncare Traders Ltd has announced 2:1 bonus issue, ex-date: 06 Mar 20
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 0 FIIs
Biogen Pharmachem Industries Limited (4.29%)
Nilmesh Infrabuild Llp (11.78%)
66.02%
Quarterly Results Snapshot (Standalone) - Mar'26 - YoY
YoY Growth in quarter ended Mar 2026 is 0.00% vs -100.00% in Mar 2025
YoY Growth in quarter ended Mar 2026 is -560.00% vs -121.05% in Mar 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Growth in half year ended Sep 2025 is -633.33% vs 108.33% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 0.00% vs -100.00% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -84.81% vs 241.07% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 0.00% vs -100.00% in Mar 2025
YoY Growth in year ended Mar 2026 is 11.86% vs 51.28% in Mar 2025






